Abstract
Introduction
Spinal anesthesia is the most commonly used neuraxial anesthetic technique for operations of the lower limbs and lower abdomen [1, 2] . Spinal anesthesia has some the advantages (e.g.
Preservation of spontaneous respiration, relaxation in the bowel and abdominal wall thus facilitating surgery) [3] , these advantages are limited by the short duration of action of local anesthetics when used alone and by side effects as hypotension and bradycardia [2, 4] , many adjuvants can been used to prolong the anesthetic and analgesic effect of local anesthetics [5] .
The quality of spinal anesthesia can be enhanced by the addition of fentanyl when added to hyperbaric bupivacaine [6] .
Dexmedetomidine, a highly selective alpha2 adrenoreceptor agonist, has been approved by Food and Drug Administration (FDA) in1999 for analgesia and sedation in the intubated patients at the intensive care [7] , when used intrathecally in animals it provided potent antinociceptive effect [8, 9] . It prolongs the sensory block by acting on presynaptic C fibers and decrease the neurotransmitter release, it prolongs the motor block by binding to motor neurons in the spinal cord [10, 11] .
Alpha-2 adrenoceptor agonists can cause hyperglycemia in humans through postsynaptice alpha 2-adrenoceptor stimulation of pancreatic B cells, thus inhibiting insulin release [12] .
ASA>II Patients
2. Diabetes mellitus, neuromuscular, hepatic, ,adrenal gland abnormality or major renal disease 3. Known allergy. to amide local anesthetics, dexmedetomidine or fentanyl. 4 . Patients using steroids, alpha 2 receptor antagonists, calcium channel blocker 5. Contraindication to spinal anesthesia (e.g. patient refusal, coagulation disorder, infection at the puncture site and tight valvular heart lesion).
Preparation of the Patients
The study protocol and the visual analogue scale (VAS) for pain were explained to the patients preoperatively.
In the operating room, a wide bore intravenous cannula was inserted, preload with 10 ml/kg Ringer solution.
Electrocardiogram, pulse oximetry, and non-invasive arterial blood pressure cuff were applied, blood glucose level measured by glucometer.
Patients were randomly allocated by closed envelope technique for randomization into four equal groups (no=25, each), to maintain the blind nature of the study, the studied drug were given by a well-trained senior anesthesiologist according to the instructions written in a sealed envelope as follows:
Group I: received 3 mL of 0.5% hyperbaric bupivacaine.
Group II: received 3 mL of 0.5% hyperbaric bupivacaine plus 3 μg dexmedetomidine (diluted in 0.5ml of normal saline) intrathecal.
Dexmedetomidine (Precedex 100 μg/ml; Hospira, Inc., Lake Forest, IL 60045 USA). Group III: received 3 mL of 0.5% hyperbaric bupivacaine plus 5 μg dexmedetomidine (diluted in 0.5ml of normal saline) intrathecal.
Original Research
Group IV: received 3 mL of 0.5% hyperbaric bupivacaine plus 25 μg fentanyl (0.5ml)
intrathecal. Fentanyl (Fentanyl-Janssen 50 μg/ml; Janssen-Cilag).
For all groups, the used hyperbaric bupivacaine is (Sunnybupivacaine 20mg/4ml; Sunny Pharmaceutical). Normal saline 0.5ml was added to the hyperbaric bupivacaine in group I to make the volume 3.5ml
Spinal anesthesia was performed under strict aseptic technique in the sitting position, 2ml
lidocaine 2% for local infiltration of the skin at L3-L4 or L4-L5 space, then insertion of 22-G Quincke type spinal needle by midline approach, when free flow of CSF was obtained the study drug was injected spinal needle was withdrawn and the patients were put in the supine position immediately, supplemented with oxygen 3 L/min by face mask.
At the end of surgery, all patients were transferred to PACU where they were monitored and discharged from the PACU to the ward, after achieved complete reversal of sensory and motor block.
The following parameters were evaluated and recorded 1-Demographic data: age, sex, weight, height 2-Hemodynamic parameters: heart rate, mean arterial blood pressure were recorded before anesthesia. After performing the spinal block the mean arterial blood pressure and heart rate were recorded every 5 minutes for the first 20 minutes and then every 15 minutes intraoperative and before the patient discharge from the PACU to the ward. Hypotension was defined as a decrease of systolic blood pressure by more than 30% from baseline or a fall below 90 mmHg and if maintained, was treated with IV fluid, incremental doses of intravenous ephedrine 5 mg as required. Bradycardia defined as a heart rate<50 beats/min, was treated with 0.5 mg of intravenous atropine.
3-Number of patients who required atropine or ephedrine intraoperatively 4-The highest level of sensory blockade assessed by pin prick. The motor block was assessed and recorded using Modified Bromage Scale (13) : Bromage 0=
the patient is able to move the hip, knee and ankle; Bromage 1= the patient is unable to move the hip, but is able to move the knee and ankle; Bromage 2= the patient is unable to move the hip and knee, but is able to move the ankle; Bromage3= the patient is unable to move the hip, knee and ankle every 2 minutes for the first l0 minutes and there after every 5 minutes until 
Results
All patients completed the study, there were no statistical significant differences between the studied groups as regards to the patient characteristics and operative data, (Table1). Intraopeartive heart rate showed no statistical significant differences between the study groups, (Table2). As regards to intraopeartive mean arterial blood pressure no statistical significant differences between the study groups except at 95 minutes, (Table3). Regarding the spinal block characteristics, no statistical significant differences between the study groups in the highest sensory level, time to reach the maximum sensory level, but time to sensory regression to S1was statistically significant lower in group I compared to the other groups, onset time to modified Bromage 3 was statistically significantly lower in group IV compared to the other groups, regression to modified Bromage 0 was statistically significant lower in group I compared to the other groups (Table 4) . No statistical significant differences between the study groups in the number of patient required atropine, ephedrine, patients required tramadol hydrochloride 50mg IV in 24 hours, complications, but the time of first request of postoperative analgesia was statistically significantly shorter in group I compared to the other groups (Table 6 ). (12) 1 (4) 2 (8) 1 (4) TFA ( The visual analogue scale was statistically significantly higher in group I compared to the other groups at 6,12 hours. Pain scores were statistically significantly lower with dexmedetomidine 3μg and 5μg than group I and group VI at 24 hours (Table7). 
Discussion
The results of the present study showed that addition of intrathecal dexmedetomidine 3 μg and 5 μg or 25 μg fentanyl to hyperbaric bupivacaine was associated with prolongation of sensory and motor block, with stable hemodynamics and minimal effect on blood glucose level, prolongation of time to first request of postoperative analgesia, reducing the postoperative pain score compared to bupivacaine alone, no postoperative complications or heavy sedation reported.
Kanazi GE and his coworkers [7] concluded that 3ug dexmedetomidine when added to intrathecal bupivacaine resulted in rapid onset of motor block, prolongation in the duration of motor and sensory block, hemodynamic stability and no sedation. Similarly It was shown that the addition of dexmedetomidine3 µg to intrathecal 0.5% hyperbaric bupivacaine 6 mg in patients undergoing transurethral prostatectomy produced fast onset and a prolonged duration of sensory block and postoperative analgesia [15] . In this study the addition of dexmedetomidine 5 ug to intrathecal heavy bupivacaine was associated with prolongation of the time to postoperative analgesic requirements and reduction in the VAS, less number of patients needed postoperative analgesia. Similar to our results, a study by Vidhi Mahendru et al [1] showed that dexmedetomidine 5 ug with 12.5 mg bupivacaine leads to prolongation of motor and sensory block, preserved hemodynamics and decreased postoperative analgesic consumed compared to clonidine 30 ug, fentanyl 25 ug, or 12.5 mg hyperbaric bupivacaine alone in patients undergoing lower limb surgery, also 5 μg dexmedetomidine as adjuvant to heavy bupivacaine 3.5 ml 0.5% provided earlier sensory and motor blockade, increase in time to first analgesic request, less postoperative analgesic requirements, with no complications in patients undergoing lower abdominal surgery under spinal anesthesia [4, 16] concluded that intrathecal dexmedetomidine 5 ug prolonged the duration of sensory and motor block of bupivacaine in adult patients undergoing surgeries below the level of umbilicus.
A meta-analysis by Xiao-Yin Niu et al [17] showed that dexmedetomidine prolonged the duration of spinal anesthesia and enhance postoperative analgesia without increasing the incidence of side effects. In this study the addition of dexmedetomidine 3 μg or 5 μg to hyperbaric bupivacaine had minimal effect on the blood glucose level, dexmedetomidine can increase blood glucose level during video gynecologic surgeries [18] and may cause hypoinsulinemia when used as sedative in icu [19] due to its effect on postsynaptic α2
adrenoreceptors on β cells of the pancreas which results in decease insulin secretion [20] .
Conclusion
The addition of intrathecal dexmedetomidine 3ug and 5ug or 25ug fentanyl to hyperbaric bupivacaine was associated with prolongation of sensory and motor block, with stable hemodynamics and minimal effect on blood glucose level, prolongation of time to first request of postoperative analgesia, and reduction of the postoperative pain scores compared to bupivacaine alone with no postoperative complications or heavy sedation reported in patients undergoing elective surgical procedures below the umbilicus.
